Molina Healthcare

Catalight Honored as a Healthy People 2030 Champion from Department of Health and Human Services

Retrieved on: 
Wednesday, November 15, 2023
Rear, Health equity, Health literacy, Research, Organization, Health Promotion International, BCBA, Doctor of Education, Disability studies, Health, HHS, Molina Healthcare, MSCP, Spectrum, Government, Nursing, MD

Walnut Creek, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Citing the company’s bold vision for the future, Catalight was recently named a Healthy People 2030 Champion by the Office of Disease Prevention and Health Promotion (ODPHP) within the U.S. Department of Health and Human Services (HHS) .

Key Points: 
  • Walnut Creek, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Citing the company’s bold vision for the future, Catalight was recently named a Healthy People 2030 Champion by the Office of Disease Prevention and Health Promotion (ODPHP) within the U.S. Department of Health and Human Services (HHS) .
  • Catalight is one of the nation’s largest non-profit providers of autism and developmental disabilities care services and research.
  • This alignment underscores the shared focus and commitment to improve the health and wellbeing for people by addressing health disparities, health equity, health literacy and social determinants of health.
  • “ODPHP is thrilled to recognize Catalight for its work to support the Healthy People 2030 vision,” said Rear Admiral Paul Reed, MD, ODPHP director.

Molina Healthcare Amends Terms for Acquisition of Bright HealthCare’s California Medicare Business

Retrieved on: 
Monday, December 18, 2023
Managed Care, Health, Health Insurance, Medicare, Health care, Molina Healthcare, Acquisition, NYSE, Pharmaceutical industry

Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that on December 13, 2023, the Company amended its purchase agreement for the acquisition of Bright HealthCare’s California Medicare business.

Key Points: 
  • Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that on December 13, 2023, the Company amended its purchase agreement for the acquisition of Bright HealthCare’s California Medicare business.
  • The purchase price for the transaction, net of certain tax benefits, is reduced from the previously announced $510 million to approximately $425 million, and now represents 23% of expected 2023 premium revenue of $1.8 billion.
  • As previously stated by Molina, the acquisition adds $1.00 per share to new store embedded earnings1 and is expected to close on or about January 1, 2024.

Ilant Health Wins for Innovative Approach to Obesity Management

Retrieved on: 
Thursday, December 14, 2023
General Health, Professional Services, Health, Human Resources, Health equity, Medicaid, Organization, Cleveland Clinic, Obesity, McKinsey & Company, Home, Population health, IMM, Molina Healthcare, HPIR, Nursing, Anthem, Medicare

Ilant Health, which provides a value-based approach to obesity treatment, is the first company to win all 3 Innovation Roundtable Academies – Employer (EHIR), Health Plan (HPIR), and Provider (PHIR).

Key Points: 
  • Ilant Health, which provides a value-based approach to obesity treatment, is the first company to win all 3 Innovation Roundtable Academies – Employer (EHIR), Health Plan (HPIR), and Provider (PHIR).
  • These groups represent over 100 innovative companies, 14 innovative health plans, and 11 leading provider systems and judging was conducted by individuals from innovative member companies such as State Farm, Premera, and Cleveland Clinic.
  • Companies are assessed for fit with market needs, innovative approach, operational fundamentals, and potential industry impact.
  • This allows Ilant to support different employer types, Medicare, and Medicaid plans, making it one of the few organizations addressing obesity health equity needs.

The MolinaCares Accord Invests $200,000 to Address Health Disparities and Inequities in Iowa

Retrieved on: 
Monday, December 11, 2023
Professional Services, Philanthropy, Health, Insurance, Health Insurance, Foundation, General Health, Health equity, Transport, United States census, Census, Risk, Community, Patient, Roflumilast, Accord, Accident, Stroke, Cancer, Partnership, Death, CDC, Housing, Family, Molina Healthcare, Food, Renewable energy, Nursing

The MolinaCares Accord (“MolinaCares”), in conjunction with Molina Healthcare of Iowa (“Molina”), presented the Iowa Primary Care Association and their member community health centers with a $200,000 grant for resources to support their work of addressing health disparities and inequities in rural and under-resourced areas throughout Iowa.

Key Points: 
  • The MolinaCares Accord (“MolinaCares”), in conjunction with Molina Healthcare of Iowa (“Molina”), presented the Iowa Primary Care Association and their member community health centers with a $200,000 grant for resources to support their work of addressing health disparities and inequities in rural and under-resourced areas throughout Iowa.
  • Accordingly, more than half of the Iowa Primary Care Association health center sites are in rural areas of the state.
  • Over the past year, community health centers in Iowa collaborated with the Iowa Primary Care Association on the Advancing Health Equity and Addressing Disparities (AHEAD) initiative.
  • The MolinaCares Accord investment also supports the 14 community health centers in their work to directly address identified inequities for their patients.

nference and Emory Healthcare Collaborate, Adding Another Top-Ranked Medical Center to Federated Data Network

Retrieved on: 
Tuesday, December 5, 2023
Software, Research, Managed Care, Oncology, Data Management, Technology, Infectious Diseases, Hospitals, Artificial Intelligence, Science, Biotechnology, Health, Confidentiality, Hope, Federal Medical Centres, Cardiology, Emory University, Privacy, Urology, Data, Patient, Multimedia, DSM-IV codes, Infection, Emory Healthcare, Hospital, AI, Geriatrics, Molina Healthcare, Pharmaceutical industry

Emory Healthcare is comprised of 11 hospitals, the Emory Clinic, and more than 250 provider locations.

Key Points: 
  • Emory Healthcare is comprised of 11 hospitals, the Emory Clinic, and more than 250 provider locations.
  • Emory Healthcare will leverage nference’s state-of-the-art capabilities to securely de-identify health information and provide Emory Healthcare with valuable insights about diseases, treatments, and outcomes for patients.
  • “This collaboration with nference allows us to join a federated data network of leading institutions that will enable ground-breaking research.
  • De-identified data remains behind firewalls at the source and is only accessible on nSights, maintaining data security and confidentiality.

Merck’s V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults, Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50 Years of Age and Older

Retrieved on: 
Tuesday, November 28, 2023
Biotechnology, Infectious Diseases, Health, Pharmaceutical, Clinical Trials, MSD, OPA, Safety, NYSE, Cohort, Merck & Co., Aes, Risk, Immunodeficiency, Patient, Molina Healthcare, GMT (TV programme), Vaccine, 9N, Fungal infection, Leucauge, Streptococcus, 20A, 10A, CDC, Attenuated vaccine, EST, Public, MRK, Pharmaceutical industry, PCV20, V116, Merck

The trial evaluated the immunogenicity, tolerability and safety of V116 compared to PCV20 (pneumococcal 20-valent conjugate vaccine) in adults who had not previously received a pneumococcal vaccine.

Key Points: 
  • The trial evaluated the immunogenicity, tolerability and safety of V116 compared to PCV20 (pneumococcal 20-valent conjugate vaccine) in adults who had not previously received a pneumococcal vaccine.
  • In adults 18 to 49 years of age (Cohort 2), V116 elicited non-inferior immune responses (immunobridged) compared to adults 50 to 64 years of age, as assessed by serotype-specific OPA GMTs 30 days post-vaccination.
  • If approved, V116 would be the first pneumococcal conjugate vaccine specifically designed for adults.
  • Participants administered V116 and PCV20 who reported at least 1 adverse event (AE) were 61.7% and 67.2%, respectively.

Toyoda Gosei Invests in ThinkCyte, a Startup Developing Devices for the Early Detection of Leukemia and Other Diseases

Retrieved on: 
Tuesday, November 28, 2023
Technology, Other Professional Services, Chemicals, Plastics, Health, Manufacturing, Finance, Pharmaceutical, Professional Services, Artificial Intelligence, Medical Devices, Software, Hardware, Other Manufacturing, Data Management, Investment, Molina Healthcare, Life expectancy, Gosei, Leukemia, Multimedia, Cell, Drug discovery, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20231127932516/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231127932516/en/
    Cell sorter developed by ThinkCyte (Graphic: Business Wire)
    ThinkCyte is a startup developing and commercializing cell analysis and sorting technology platform using AI-based cell image analysis.
  • The company’s technology to analyze individual cells and sort them will enable faster and more accurate diagnoses than conventional methods.
  • Toyoda Gosei has been focusing efforts on product development and collaboration with companies in the field of preventive medicine, to help increase life expectancy.
  • * Investment made in October 2023, through Toyoda Gosei’s Corporate Venture Capital Dept., an internal organization dedicated to these investments.

More Than 1,100 Physicians, Health Care Professionals, and Scientists Boycott Medical Journal

Retrieved on: 
Monday, November 20, 2023
Research, Animal Welfare, Publishing, Public Policy, Government, Communications, Clinical Trials, Health, Pharmaceutical, Science, Infant, Policy, Ethics, Milk, Animal, MDPI, University, MD, MPH, Human, Molina Healthcare, Letter, Medical device, Dietary supplement, Nutrient

The boycott, which also applies to Nutrients’ publisher, MDPI, comes after repeated requests to the journal’s editors asking them to institute sound editorial practices.

Key Points: 
  • The boycott, which also applies to Nutrients’ publisher, MDPI, comes after repeated requests to the journal’s editors asking them to institute sound editorial practices.
  • A letter sent to those editors today, Nov. 20, 2023, says “As a community of scientists and health care professionals, we have lost confidence in Nutrients and MDPI.
  • Pigs were fed different infant formulas and human milk with and without an added probiotic and had their gut microbiota analyzed.
  • Richard Schmidt, MD, an obstetrician and gynecologist who specializes in fertility problems in Mountainview, Calif., is among those who are boycotting the journal.

Oscar Health, Inc. Announces 2023 Culturally Competent Care Grant Recipients, Bolstering its Efforts to Support Rural and Hispanic and Latino Communities

Retrieved on: 
Monday, November 20, 2023
Professional Services, Public Policy, Government, Healthcare Reform, Health, Health Technology, Insurance, Health equity, NYSE, Organization, CCC, Molina Healthcare, Patient, ACA, CHW, OSCR, Transport

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants.
  • The initiative, which is a component of Oscar’s CCC Program, delivers financial and on-the-ground support to select organizations who provide access to care in underserved communities.
  • With the funding, CHW anticipates serving an additional 500 individuals, and developing new Spanish literacy trainings and educational materials for the community.
  • Oscar launched the grant initiative in 2021, as a key pillar of the CCC Program, to impact change at the community level.

Small Door Veterinary Expands in Washington D.C. With New Location in Spring Valley Neighborhood

Retrieved on: 
Thursday, November 16, 2023
Pets, Professional Services, Small Business, Family, Veterinary, Consumer, Other Retail, Commercial Building & Real Estate, Construction & Property, Health, Specialty, Health Technology, Telemedicine, Virtual Medicine, Retail, Other Professional Services, Other Consumer, Parenting, Pet, Brown University, Entrepreneurship, Cardiology, B Corporation (certification), Internal medicine, AAHA, Veterinary medicine, Accreditation, Veterinarian, Maret School, Parental leave, University, Molina Healthcare, Dermatology, Telehealth, American Animal Hospital Association, Geriatrics, Biology, Dentistry, Trapping

Small Door Inc., a tech-enabled, membership-based veterinary care provider that operates under the brand Small Door Veterinary , today expanded its footprint in the Washington, D.C. market with the opening of its state-of-the-art practice in Spring Valley (4301 49th Street, NW).

Key Points: 
  • Small Door Inc., a tech-enabled, membership-based veterinary care provider that operates under the brand Small Door Veterinary , today expanded its footprint in the Washington, D.C. market with the opening of its state-of-the-art practice in Spring Valley (4301 49th Street, NW).
  • The new Spring Valley facility is the third location to open in the city this year, as Small Door continues to address a growing need for vet care amongst D.C. pet owners.
  • The opening marks the tenth location across three markets that Small Door has entered, with five New York City locations and two Boston practices that opened earlier this year.
  • As Small Door continues to expand in the DC market, Spring Valley was an ideal neighborhood to serve our target customer,” said Josh Guttman, Co-Founder and CEO of Small Door.